CUA: A new way to zap the prostate—MRI-guided laser ablationOutpatient procedure has low morbidity but high failure rate CUA: Survey reveals gaps in genitourinary cancer survivorship care Xtandi: new oral androgen receptor inhibitor for metastatic prostate cancer Drug is intended for patients who have undergone medical or surgical castration and who have received docetaxel therapy. U.S. guideline nixes prostate screening in under-55s Prostate cancer: More men can opt for active surveillance All conventional criteria need not be fulfilled, analysis shows Late toxicities of cancer drugs Cardiac, pulmonary, sexual, and neurologic toxicities that develop or persist after completing cancer drug therapy Prostate cancer: More men can opt for active surveillance Not all conventional criteria need to be fulfilled, analysis shows New U.S. guideline nixes prostate cancer screening in under-55s Two-year interval suggested for older men who opt for testing Robot fails to impress in bladder cancer surgery High-tech approach no better than conventional open procedure Implants a cancer hazard First Previous 43 44 45 46 47 Next Last
